Trial
NCT01814813
Vaccine Therapy With Bevacizumab Versus Bevacizumab Alone in Treating Patients With Recurrent Glioblastoma Multiforme That Can Be Removed by Surgery
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Alliance for Clinical Trials in Oncology
Collaborators
National Cancer Institute (NCI); Agenus Inc.
Condition
Recurrent Glioblastoma
Intervention
HSPPC-96
Why stopped
DSMB futility analysis
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-01-24